Naproxenum, Esomeprazolum
| Medicinal product name | Vimovo 500 mg/20 mg modified-release tablets |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Modified-release tablet | |||||||||
| Strength | 500 mg/20 mg | |||||||||
| Information from the MAH on shortages | No information on expected shortages | |||||||||
| Availability of medicinal product |
|
|||||||||
| Legal status | Prescription (Pr.) | |||||||||
| Package leaflet |  19-10-2021
|
|||||||||
| Summary of product characteristics | 19-10-2021
|
|||||||||
| ATC code | M01AE52 – Antiinflammatory and antirheumatic products |
Medicinal products (13)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N6 (500 mg/20 mg) |
HDPE bottle | 10-0640-01 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (500 mg/20 mg) |
HDPE bottle | 10-0640-02 |
Labelling text Oct 19, 2021 |
|
|
Is available (according to the information provided by wholesalers) (196 containers) |
Tamro, Magnum Medical, Euroaptieka, Recipe Plus |
N30 (500 mg/20 mg) |
HDPE bottle | € 17.28 | 10-0640-03 |
Labelling text Oct 19, 2021 |
|
Is available (according to the information provided by wholesalers) (139 containers) |
Tamro, Magnum Medical, Euroaptieka, Recipe Plus |
N60 (500 mg/20 mg) |
HDPE bottle | € 30.20 | 10-0640-04 |
Labelling text Oct 19, 2021 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (500 mg/20 mg) |
HDPE bottle | 10-0640-05 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N180 (500 mg/20 mg) |
HDPE bottle | 10-0640-06 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N500 (500 mg/20 mg) |
HDPE bottle | 10-0640-07 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (500 mg/20 mg) |
Al/Al blister | 10-0640-08 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (500 mg/20 mg) |
Al/Al blister | 10-0640-09 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (500 mg/20 mg) |
Al/Al blister | 10-0640-10 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (500 mg/20 mg) |
Al/Al blister | 10-0640-11 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (500 mg/20 mg) |
Al/Al blister | 10-0640-12 |
Labelling text Oct 19, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (500 mg/20 mg) |
HDPE bottle | 10-0640-13 |
Labelling text Oct 19, 2021 |
Registration information
| Marketing authorisation No. | 10-0640 |
|---|---|
| Date of authorisation | Dec 30, 2010 |
| MA valid until | For unlimited time |
| Marketing authorisation holder, country | AstraZeneca AB, Sweden |
